For the year ending 2025-12-31, NAUT has $191,112K in assets. $34,139K in debts. $12,388K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 12,388 | |||
| Short-term investments | 91,018 | |||
| Prepaid expenses and other current assets | 2,557 | |||
| Total current assets | 105,963 | |||
| Property and equipment, net | 3,457 | |||
| Operating lease right-of-use assets | 27,773 | |||
| Long-term investments | 52,739 | |||
| Other long-term assets | 1,180 | |||
| Total assets | 191,112 | |||
| Accounts payable | 943 | |||
| Accrued expenses and other liabilities | 3,177 | |||
| Current portion of operating lease liability | 3,832 | |||
| Total current liabilities | 7,952 | |||
| Operating lease liability, net of current portion | 26,187 | |||
| Total liabilities | 34,139 | |||
| Common stock, 0.0001 par value, 1,000,000,000 shares authorized as of december 31, 2025 and 2024, respectively 126,469,610 and 126,106,176 shares issued and outstanding as of december 31, 2025 and 2024, respectively | 13 | |||
| Additional paid-in capital | 488,737 | |||
| Accumulated other comprehensive income | 243 | |||
| Accumulated deficit | -332,020 | |||
| Total stockholders equity | 156,973 | |||
| Total liabilities and stockholders equity | 191,112 | |||
Nautilus Biotechnology, Inc. (NAUT)
Nautilus Biotechnology, Inc. (NAUT)